Article Text

This article has a correction. Please see:

PDF
Dynamic CpG methylation of the KCNQ1OT1 gene during maturation of human oocytes
  1. R Khoureiry1,
  2. S Ibala-Rhomdane1,2,
  3. L Méry1,
  4. T Blachère1,
  5. J-F Guérin1,
  6. J Lornage1,
  7. A Lefèvre1
  1. 1
    INSERM U846, Laboratoire de Biologie de la Reproduction, Faculté de Médecine, Lyon, France
  2. 2
    Service de Cytogénétique et Biologie de la Reproduction, CHU Farhat Hached, Sousse, Tunisia
  1. Dr A Lefèvre, INSERM U846, Laboratoire de Biologie de la Reproduction, Faculté de Médecine, 8 avenue Rockefeller, 69373 Lyon cedex 8, France; annick.lefevre{at}inserm.fr

Abstract

Background: Imprinted genes, many of which are involved in development, are marked during gametogenesis to allow their parent-of-origin specific expression, and DNA methylation at CpG islands is part of this epigenetic mark. Maternal imprint is apposed on oocyte during growth and maturation. Factors interfering with normal oocyte differentiation such as gonadotrophin stimulation and in vitro maturation (IVM) may possibly alter imprint resetting.

Methods: We examined the methylation of the KCNQ1OT1 differentially methylated region (KvDMR1) in human oocytes at different stages of their development: germinal vesicle (GV), metaphase I (MI) or metaphase II (MII).

Results: About 60% of alleles were fully methylated in GV oocytes and that full imprint is acquired in most MII oocytes. Similarly to in vivo, de novo methylation of DNA occurred in vitro during oocyte maturation. Following in vitro culture for 28 h, GV and MI oocytes are significantly more methylated when they are obtained from natural cycles than from patients undergoing gonadotrophin stimulation.

Conclusion: This observation suggests that hyperstimulation likely recruits young follicles that are unable to acquire imprint at KvDMR1 during the course of the maturing process.

Statistics from Altmetric.com

Footnotes

  • Funding: RK was a recipient of Organon and Lebanon CNRS fellowships. This work was supported by a grant from Agence de la Biomédecine “R06106CC”.

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd